Hi Stevie,
what price range are you anticipating for re-rate?
No doubt we'll break past previous ATH.
Tightly held, addressable market is huge, credible team and board, financially secured for P1 with pre-clinical results pointing to safe and favourable results
Held since IPO, day one it's had a unicorn feel to it. Their rate of progress and the potential effectiveness of ARG-007 itself relative our closest competitor is astounding, enough to make it to state news. '20 years in the making'
Cheers
Ann: Ethics Application Submitted for Phase 1 Trial, page-8
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
76.0¢ |
Change
0.020(2.70%) |
Mkt cap ! $97.35M | |||
| Open | High | Low | Value | Volume |
| 73.5¢ | 76.0¢ | 72.3¢ | $96.97K | 130.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | 73.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 76.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 15.40pm 27/09/2024 (20 minute delay) ? |
| AGN (ASX) Chart |